{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:27:09Z","timestamp":1783546029390,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T00:00:00Z","timestamp":1256515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T00:00:00Z","timestamp":1256515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/bmt.2009.308","type":"journal-article","created":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T11:49:02Z","timestamp":1256557742000},"page":"1095-1101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL"],"prefix":"10.1038","volume":"45","author":[{"given":"S","family":"Giebel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Stella-Holowiecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Krawczyk-Kulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Hoelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Doubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Piatkowska-Jakubas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A B","family":"Skotnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P P","family":"Piccaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Czerw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kyrcz-Krzemien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Holowiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Study Group for Adult ALL (EWALL) of the European Leukemia Net","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,26]]},"reference":[{"key":"BFbmt2009308_CR1","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1182\/blood-2007-05-038950","volume":"110","author":"JM Rowe","year":"2007","unstructured":"Rowe JM, Goldstone AH . How I treat acute lymphocytic leukemia in adults. Blood 2007; 110: 2268\u20132275.","journal-title":"Blood"},{"key":"BFbmt2009308_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V71.1.123.123","volume":"71","author":"D Hoelzer","year":"1988","unstructured":"Hoelzer D, Thiel E, L\u00f6ffler H, B\u00fcchner T, Ganser A, Heil G et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123\u2013131.","journal-title":"Blood"},{"key":"BFbmt2009308_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbmt.2005.10.018","volume":"12","author":"T Hahn","year":"2006","unstructured":"Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant 2006; 12: 1\u201330.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2009308_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.seminhematol.2007.08.004","volume":"44","author":"R Willemze","year":"2007","unstructured":"Willemze R, Labar B . Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation? Semin Hematol 2007; 44: 267\u2013273.","journal-title":"Semin Hematol"},{"key":"BFbmt2009308_CR5","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","volume":"22","author":"X Thomas","year":"2004","unstructured":"Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075\u20134086.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009308_CR6","first-page":"1346","volume":"90","author":"JM Ribera","year":"2005","unstructured":"Ribera JM, Oriol A, Bethencourt C, Parody R, Hern\u00e1ndez-Rivas JM, Moreno MJ et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica 2005; 90: 1346\u20131356.","journal-title":"Haematologica"},{"key":"BFbmt2009308_CR7","first-page":"809","volume":"89","author":"B Labar","year":"2004","unstructured":"Labar B, Suciu S, Zittoun R, Muus P, Marie JP, Fillet G et al. Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial. Haematologica 2004; 89: 809\u2013817.","journal-title":"Haematologica"},{"key":"BFbmt2009308_CR8","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"AH Goldstone","year":"2008","unstructured":"Goldstone AH, Richards SM, Lazarus HM, Goldstone AH, Richards SM, Lazarus HM et al. In adults with standard-risk acute lymphoblastic leukemia (ALL) the greatest benefit is achieved from a matched sibling allogeneic transplant in first complete remission (CR) and an autologous transplant is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the international ALL trial (MRC UKALL XII\/ECOG E2993). Blood 2008; 111: 1827\u20131833.","journal-title":"Blood"},{"key":"BFbmt2009308_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.leu.2404065","volume":"20","author":"N Dh\u00e9din","year":"2006","unstructured":"Dh\u00e9din N, Dombret H, Thomas X, Lh\u00e9ritier V, Boiron JM, Rigal-Huguet F et al. Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials. Leukemia 2006; 20: 336\u2013344.","journal-title":"Leukemia"},{"key":"BFbmt2009308_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/10428190290006099","volume":"43","author":"J Ho\u0142owiecki","year":"2002","unstructured":"Ho\u0142owiecki J, Giebel S, Krzemie\u0144 S, Krawczyk-Kuli\u015b M, Jagoda K, Kopera M et al. G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter study. Leuk Lymphoma 2002; 43: 315\u2013325.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2009308_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2141.2008.07185.x","volume":"142","author":"J Holowiecki","year":"2008","unstructured":"Holowiecki J, Krawczyk-Kulis M, Giebel S, Jagoda K, Stella-Holowiecka B, Piatkowska-Jakubas B et al. Status of minimal residual disease after induction predicts outcome in both standard and high risk Ph-negative adult acute lymphoblastic leukemia. The Polish Adult Leukemia Group ALL 4-2002 MRD study. Br J Haematol 2008; 142: 227\u2013237.","journal-title":"Br J Haematol"},{"key":"BFbmt2009308_CR12","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","volume":"107","author":"M Br\u00fcggemann","year":"2006","unstructured":"Br\u00fcggemann M, Raff T, Flohr T, G\u00f6kbuget N, Nakao M, Droese J et al. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 2006; 107: 1116\u20131123.","journal-title":"Blood"},{"key":"BFbmt2009308_CR13","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V86.4.1619.bloodjournal8641619","volume":"86","author":"M Attal","year":"1995","unstructured":"Attal M, Blaise D, Marit G, Payen C, Michallet M, Vernant JP et al. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. Blood 1995; 86: 1619\u20131628.","journal-title":"Blood"},{"key":"BFbmt2009308_CR14","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2006-03-011908","volume":"109","author":"A de Labarthe","year":"2007","unstructured":"de Labarthe A, Rousselot P, Huguet-Rigal F, Delabesse E, Witz F, Maury S et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood 2007; 109: 1408\u20131413.","journal-title":"Blood"},{"key":"BFbmt2009308_CR15","first-page":"1346","volume":"90","author":"JM Ribera","year":"2005","unstructured":"Ribera JM, Oriol A, Bethencourt C, Parody R, Hern\u00e1ndez-Rivas JM, Moreno MJ et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica 2005; 90: 1346\u20131356.","journal-title":"Haematologica"},{"key":"BFbmt2009308_CR16","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1182\/blood-2004-07-2922","volume":"105","author":"M Mancini","year":"2005","unstructured":"Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, Elia L et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood 2005; 105: 3434\u20133441.","journal-title":"Blood"},{"key":"BFbmt2009308_CR17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/sj.leu.2402150","volume":"15","author":"P Lucio","year":"2001","unstructured":"Lucio P, Gaipa G, van Lochem EG, van Wering ER, Porwit-MacDonald A, Faria T et al. BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standarized triple-stainings. Leukemia 2001; 15: 1185\u20131192.","journal-title":"Leukemia"},{"key":"BFbmt2009308_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.leu.2401741","volume":"14","author":"A Porwit-MacDonald","year":"2000","unstructured":"Porwit-MacDonald A, Bjorklund E, Lucio P, van Lochem EG, Mazur J, Parreira A et al. BIOMED-1 Concerted Action report: Flow cytometric characterisation of CD7 cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL). Leukemia 2000; 14: 816\u2013825.","journal-title":"Leukemia"},{"key":"BFbmt2009308_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.leu.2401279","volume":"13","author":"P Lucio","year":"1999","unstructured":"Lucio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia 1999; 13: 419\u2013427.","journal-title":"Leukemia"},{"key":"BFbmt2009308_CR20","first-page":"1069","volume":"83","author":"J Ciudad","year":"1998","unstructured":"Ciudad J, Orfao A, Vidriales B, Macedo A, Mart\u00ednez A, Gonz\u00e1lez M et al. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Haematologica 1998; 83: 1069\u20131075.","journal-title":"Haematologica"},{"key":"BFbmt2009308_CR21","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program. Leukemia 2003; 17: 2318\u20132357.","journal-title":"Leukemia"},{"key":"BFbmt2009308_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2009308_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life tables. J Royal Soc B 1972; 34: 187\u2013220.","journal-title":"J Royal Soc B"},{"key":"BFbmt2009308_CR24","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1200\/JCO.2004.07.130","volume":"22","author":"MG Kiehl","year":"2004","unstructured":"Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol 2004; 22: 2816\u20132825.","journal-title":"J Clin Oncol"},{"key":"BFbmt2009308_CR25","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/leu.2008.386","volume":"23","author":"M Zaliova","year":"2009","unstructured":"Zaliova M, Fronkova E, Krejcikova K, Muzikova K, Mejstrikova E, Stary J et al. Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR\/ABL-positive ALL: implications for residual disease monitoring. Leukemia 2009; 23: 944\u2013951.","journal-title":"Leukemia"},{"key":"BFbmt2009308_CR26","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.leu.2404603","volume":"21","author":"T Szczepa\u0144ski","year":"2007","unstructured":"Szczepa\u0144ski T . Why and how to quantify minimal residual disease in acute lymphoblastic leukemia? Leukemia 2007; 21: 622\u2013626.","journal-title":"Leukemia"},{"key":"BFbmt2009308_CR27","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","volume":"99","author":"MJ Willemse","year":"2002","unstructured":"Willemse MJ, Seriu T, Hettinger K, d'Aniello E, Hop WC, Panzer-Gr\u00fcmayer ER et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood 2002; 99: 4386\u20134393.","journal-title":"Blood"},{"key":"BFbmt2009308_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF01715137","volume":"68","author":"H Martin","year":"1994","unstructured":"Martin H, Atta J, Bruecher J, Elsner S, Schardt C, Stadler M et al. In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT. Ann Hematol 1994; 68: 85\u201387.","journal-title":"Ann Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009308","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T22:39:42Z","timestamp":1739399982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,26]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFbmt2009308"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.308","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,26]]},"assertion":[{"value":"2 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}